Vikas Sinha
President and Chief Financial Officer
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2024-12-19–2025-03-18
-
Start not stated–2025-03-18
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Kalaris Therapeutics, Inc. (KLRS) | AlloVir’s Former Chief Executive Officer, President and Chief Financial Officer | $81,106 | $1,100,954 |
| 2024 | Kalaris Therapeutics, Inc. (KLRS) | AlloVir’s Former Chief Executive Officer, President and Chief Financial Officer | $375,448 | $544,400 |
| 2023 | Kalaris Therapeutics, Inc. (KLRS) | AlloVir’s Former Chief Executive Officer, President and Chief Financial Officer | $373,042 | $2,940,669 |
| 2022 | Kalaris Therapeutics, Inc. (KLRS) | President and Chief Financial Officer | $369,007 | $2,904,162 |
| 2021 | Kalaris Therapeutics, Inc. (KLRS) | President and Chief Financial Officer | $425,000 | $6,622,996 |
| 2020 | Kalaris Therapeutics, Inc. (KLRS) | President and Chief Financial Officer | $412,000 | $6,320,540 |
| 2019 | Kalaris Therapeutics, Inc. (KLRS) | President and ChiefFinancial Officer | $400,000 | $1,629,646 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.